After 2 years of follow-up, the levels of Sec62 were much higher in tumour tissues with early recurrence (20/60) than in non-recurrent tumours (40/60) (Fig. 1a left and Fig. 1Sa). This evidence concerns the gene SEC62 and neoplasm.